The top documents tagged [critical path initiative]

The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents
Documents The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents

6.299 views

FDA/Industry Workshop September 14-16, 2005 Critical Path Initiative: What it means for pharmaceutical industry statisticians Walter Offen, Lilly Brenda
Documents FDA/Industry Workshop September 14-16, 2005 Critical Path Initiative: What it means for pharmaceutical industry statisticians Walter Offen, Lilly Brenda

217 views

An Update on FDAs Critical Path Initiative Statistical Contributions Robert T. ONeill Ph.D. Director, Office of Biostatistics Center for Drug Evaluation
Documents An Update on FDAs Critical Path Initiative Statistical Contributions Robert T. ONeill Ph.D. Director, Office of Biostatistics Center for Drug Evaluation

215 views

Evaluating the value of research-by-consortium: Science of Team Science
Leadership & Management Evaluating the value of research-by-consortium: Science of Team Science

146 views

PGx Testing
Documents PGx Testing

36 views

1 Overview of Pharmaceutical Technology and Education Areas: Industrialization Pharmaceutical Technology Manufacturing Science Pharmaceutical Engineering
Documents 1 Overview of Pharmaceutical Technology and Education Areas: Industrialization Pharmaceutical Technology Manufacturing Science Pharmaceutical Engineering

243 views

1 The ACTION Public-Private Partnership: Background, Rationale, and Objectives Bob A. Rappaport, M.D. Director Division of Anesthesia, Analgesia, and Addiction
Documents 1 The ACTION Public-Private Partnership: Background, Rationale, and Objectives Bob A. Rappaport, M.D. Director Division of Anesthesia, Analgesia, and Addiction

215 views

Oncology Dose Finding A Case Study: Intra-patient Dose Escalation Jonas Wiedemann, Meghna Kamath Samant & Dominik Heinzmann, pRED Biostatistics, Valerie
Documents Oncology Dose Finding A Case Study: Intra-patient Dose Escalation Jonas Wiedemann, Meghna Kamath Samant & Dominik Heinzmann, pRED Biostatistics, Valerie

232 views

The Critical Path Opportunities for Efficiency in Development Robert J. Temple, M.D. Associate Director for Medical Policy Center for Drug Evaluation and
Documents The Critical Path Opportunities for Efficiency in Development Robert J. Temple, M.D. Associate Director for Medical Policy Center for Drug Evaluation and

220 views

Use of Biomarker Information in Drug Product Labels to Individualize Pharmacotherapy Lawrence J. Lesko, Ph.D., FCP Director of the Office of Clinical Pharmacology
Documents Use of Biomarker Information in Drug Product Labels to Individualize Pharmacotherapy Lawrence J. Lesko, Ph.D., FCP Director of the Office of Clinical Pharmacology

218 views

Cellular Tissue and Gene Therapies Research Site Visit Celia M.Witten, Ph.D., M.D. Director, Office of Cellular, Tissue, and Gene Therapies September 29,
Documents Cellular Tissue and Gene Therapies Research Site Visit Celia M.Witten, Ph.D., M.D. Director, Office of Cellular, Tissue, and Gene Therapies September 29,

221 views